Bioqual Net Income 2010-2024 | BIOQ
Bioqual net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Bioqual Annual Net Income
(Millions of US $) |
| 2024 |
$0 |
| 2023 |
$1 |
| 2022 |
$5 |
| 2021 |
$6 |
| 2020 |
$4 |
| 2019 |
$3 |
| 2018 |
$4 |
| 2017 |
$4 |
| 2016 |
$3 |
| 2015 |
$2 |
| 2013 |
$-0 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2010 |
$0 |
| 2009 |
$1 |
Bioqual Quarterly Net Income
(Millions of US $) |
| 2024-11-30 |
$-1 |
| 2024-08-31 |
$-1 |
| 2024-05-31 |
$-1 |
| 2024-02-29 |
$0 |
| 2023-11-30 |
$0 |
| 2023-08-31 |
$1 |
| 2023-05-31 |
$-1 |
| 2023-02-28 |
$-1 |
| 2022-11-30 |
$1 |
| 2022-08-31 |
$1 |
| 2022-05-31 |
$2 |
| 2022-02-28 |
$1 |
| 2021-11-30 |
$1 |
| 2021-08-31 |
$1 |
| 2021-05-31 |
$2 |
| 2021-02-28 |
$1 |
| 2020-11-30 |
$1 |
| 2020-08-31 |
$2 |
| 2020-05-31 |
$1 |
| 2020-02-29 |
$1 |
| 2019-11-30 |
$1 |
| 2019-08-31 |
$1 |
| 2019-05-31 |
$1 |
| 2019-02-28 |
$0 |
| 2018-11-30 |
$1 |
| 2018-08-31 |
$1 |
| 2018-05-31 |
$1 |
| 2018-02-28 |
$1 |
| 2017-11-30 |
$1 |
| 2017-08-31 |
$1 |
| 2017-05-31 |
$1 |
| 2017-02-28 |
$1 |
| 2016-11-30 |
$1 |
| 2016-08-31 |
$1 |
| 2016-05-31 |
$1 |
| 2016-02-29 |
$1 |
| 2015-11-30 |
$1 |
| 2015-08-31 |
$0 |
| 2015-05-31 |
$1 |
| 2015-02-28 |
$0 |
| 2014-08-31 |
$0 |
| 2014-05-31 |
$0 |
| 2013-11-30 |
$0 |
| 2013-08-31 |
$0 |
| 2013-05-31 |
$0 |
| 2012-05-31 |
$-0 |
| 2012-02-29 |
$0 |
| 2011-11-30 |
$0 |
| 2011-08-31 |
$0 |
| 2011-05-31 |
$0 |
| 2011-02-28 |
$0 |
| 2010-11-30 |
$0 |
| 2010-08-31 |
$-0 |
| 2010-05-31 |
$0 |
| 2010-02-28 |
$0 |
| 2009-11-30 |
$0 |
| 2009-08-31 |
$0 |
| 2009-05-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.055B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
